Aquestive Therapeutics, Inc.
AQST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$15,446 | -$13,548 | -$22,930 | -$17,055 |
| Dep. & Amort. | $139 | $140 | $139 | $147 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,777 | $1,884 | $1,587 | $2,403 |
| Change in WC | -$2,878 | $919 | -$4,992 | $5,284 |
| Other Non-Cash | $2,759 | $2,691 | $2,796 | $2,732 |
| Operating Cash Flow | -$12,649 | -$7,914 | -$23,400 | -$6,489 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$235 | -$107 | -$135 | -$15 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$235 | -$107 | -$135 | -$15 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$7 | -$8 | -$11 | -$5 |
| Stock Issued | $79,719 | -$124 | $21,360 | -$34 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,699 | $32 | -$703 | $196 |
| Financing Cash Flow | $81,411 | -$100 | $20,646 | $157 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $68,527 | -$8,121 | -$2,889 | -$6,347 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60,536 | $68,657 | $71,546 | $77,893 |
| End Cash | $129,063 | $60,536 | $68,657 | $71,546 |
| Free Cash Flow | -$12,884 | -$8,021 | -$23,535 | -$6,504 |